Investor Presentaiton

Why to invest in Orion NubeqaⓇ main growth driver in short and mid-term ORION Long history and proven track record Long-term growth drivers from R&D pipeline GROWTH INNOVATION Strong commitment to innovation Global pharma market growing 3-6% per annum. Diversified business divisions balance each others and aim for solid growth 3 Proven track record in delivering financial results. Investor Presentation Orion Corporation STABILITY Robust R&D pipeline with focus in pain and oncology Strong profitability Predictable and growing dividend

View entire presentation